Peptide Synthesis Market worth $859 million | MarketsandMarkets
Comunicato Precedente
Comunicato Successivo
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365
Browse in-depth TOC on "Peptide Synthesis Market"
238 - Tables
41 - Figures
257 - Pages
Peptide Synthesis Market Scope:
The reagents segment accounted for the largest share of the product & service segment in the peptide synthesis market in 2022.
Based on product & service, the peptide synthesis market is segmented into reagents, equipment, and services. In 2022, the reagents segment accounted for the largest share of the peptide synthesis market. The large share of this segment is fueled by the increasing demand for peptide-based therapeutics, advancements in synthesis technologies, expanding research and development activities, the rise of contract research and manufacturing organizations, and the availability of various peptide synthesis reagents in the market.
The Solid Phase peptide synthesis segment accounted for the largest share of the technology segment in the peptide synthesis market in 2022.
Based on technology, the peptide synthesis market is segmented into solid-phase peptide synthesis, solution-phase peptide synthesis, and hybrid & recombinant technology. The solid-phase peptide synthesis segment accounted for the largest share in the peptide synthesis market in 2022. Solid-phase peptide synthesis is associated offers various advantages such as ease of operation, easy purification, short production cycles, high-level automation, and synthesis capabilities of long peptides in small quantities of amino acids. These advantages support the growth of the solid-phase peptide synthesis segment.
Asia Pacific is likely to grow at the highest growth rate during the forecast period.
Based on the region, peptide synthesis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the peptide synthesis market during the forecast period. The growth of the pharmaceuticals and life sciences market in the region is primarily driven by the rising R&D expenditure, especially in the area of drug discovery & development, the rising prevalence of chronic disease conditions, and significant investments in the development of therapeutics mAbs.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365
Peptide Synthesis Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Key Market Players:
The prominent players operating in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland).
Recent Developments:
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=158927365
Peptide Synthesis Market Advantages:
In conclusion, the peptide synthesis market offers several advantages, including customization, therapeutic potential, technological advancements, growing demand in various applications, and its role in personalized medicine. These factors contribute to the industry's growth and its potential to drive innovation in healthcare, research, and industrial sectors.
High-Throughput Screening Market - Report Highlights:
Related Reports:
Proteomics Market - Global Forecasts to 2028
Pharmaceutical Contract Manufacturing Market - Global Forecasts to 2028
Protein Expression Market - Global Forecasts to 2027
Oligonucleotide Synthesis Market - Global Forecasts to 2027
Chromatography Accessories and Consumables Market - Global Forecasts to 2027
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/peptide-synthesis-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/peptide-synthesis.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/peptide-synthesis-market-worth-859-million--marketsandmarkets-301874016.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
